CJC-1295 with DAC

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide analog of Growth Hormone-Releasing Hormone (GHRH), distinguished in preclinical research by its incorporation of a specialized affinity complex designed to extend its operational half-life. As a research-use-only material, CJC-1295 with DAC is provided exclusively for academic and experimental investigations in vitro or in vivo under controlled conditions. This description outlines its chemical properties, relevant scientific applications, and safety considerations in a research context.

Research Overview

CJC-1295 with DAC has been extensively investigated for its ability to maintain constant binding affinity with GHRH receptors on the anterior pituitary gland. Unlike standard GHRH analogs that stimulate a brief, pulsatile release of endogenous growth hormone (GH), the addition of the DAC complex allows for continuous stimulation, resulting in elevated, steady-state baselines of growth hormone in research models. Preclinical studies focus on how this persistent receptor occupancy alters downstream metabolic signaling, drives continuous Insulin-like Growth Factor 1 (IGF-1) production, and impacts long-term cellular repair and cellular energy homeostasis without the requirement of frequent dosing protocols.

Key Research Focus Areas

• Extended Recombinant Kinetics: Evaluation of the dynamic interaction between the Drug Affinity Complex and biological albumin to measure prolonged half-life extension.

• Continuous Pituitary Stimulation: Investigation of CJC-1295 with DAC’s role in shifting growth hormone release from standard pulsatile spikes to a continuous, elevated baseline.

• Downstream IGF-1 Homeostasis: Exploration of how steady-state growth hormone elevation influences the uniform, long-term synthesis of Insulin-like Growth Factor 1.

• Long-Term Metabolic Profiling: Researching the compound’s impact on chronic lipid oxidation, nitrogen retention, and cellular tissue remodeling in animal models.

Important Cautionary Statement

This peptide is for research use only and should be handled with extreme care. Preclinical studies have shown potential biological effects, but its safety, efficacy, and potential risks in human or animal contexts remain largely unexplored. Users must adhere to strict ethical guidelines and regulatory requirements applicable to their institution. Misuse or improper handling may result in unintended consequences.

Compliance Notice

For research use only. Not for human or animal consumption. Adherence to all applicable local, national, and international laws and regulations governing research chemicals is mandatory. Users are responsible for ensuring compliance with their institution’s policies and any relevant scientific or legal frameworks.